Prevalence of vertebral fractures and serum sclerostin levels in acromegaly

被引:0
作者
Meliha Melin Uygur
Dilek Dereli Yazıcı
Onur Buğdaycı
Dilek Gogas Yavuz
机构
[1] Marmara University School of Medicine,Division of Endocrinology and Metabolism
[2] Marmara University School of Medicine,Department of Radiology
来源
Endocrine | 2021年 / 73卷
关键词
Acromegaly; Bone turnover markers; Vertebral fracture; Sclerostin; Hypogonadism; Radiosurgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:667 / 673
页数:6
相关论文
共 106 条
[1]  
Colao A(2019)Acromegaly Nat. Rev. Dis. Prim. 5 20-R56
[2]  
Grasso LFS(2019)Management of endocrine disease: bone disorders associated with acromegaly: mechanisms and treatment Eur. J. Endocrinol. 181 R45-59
[3]  
Giustina A(2008)Growth hormone, insulin-like growth factors, and the skeleton Endocr. Rev. 29 535-44
[4]  
Melmed S(2005)Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women J. Bone Min. Res. 20 1837-94
[5]  
Chanson P(2015)Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis J. Clin. Endocrinol. Metab. 100 384-55
[6]  
Pereira AM(2008)Prevalence of vertebral fractures in men with acromegaly J. Clin. Endocrinol. Metab. 93 4649-15
[7]  
Mazziotti G(2011)High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly Eur. J. Endocrinol. 164 475-10
[8]  
Lania AGA(2013)Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study J. Clin. Endocrinol. Metab. 98 4808-37
[9]  
Canalis E(2013)Vertebral fractures in patients with acromegaly: a 3-year prospective study J. Clin. Endocrinol. Metab. 98 3402-R85
[10]  
Giustina A(2020)A consensus on the diagnosis and treatment of acromegaly comorbidities: an update J. Clin. Endocrinol. Metab. 105 4-20